Figure 2. Management overview of low prognosis patients according to POSEIDON groups 1 and 2. Reprint from: Conforti et al. Management of Women With an Unexpected Low Ovarian Response to Gonadotropin. Front Endocrinol. 2019;10:387. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).